Vijender Panduga

Bellary Road
Bengaluru, KA 560024, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Journal: ACS medicinal chemistry letters

Published: July 29, 2019

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Journal: Journal of medicinal chemistry

Published: January 12, 2017

Evaluation of the metabolism, bioactivation and pharmacokinetics of triaminopyrimidine analogs toward selection of a potential candidate for antimalarial therapy.

Evaluation of the metabolism, bioactivation and pharmacokinetics of triaminopyrimidine analogs toward selection of a potential candidate for antimalarial therapy.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: October 19, 2016

In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.

In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment.

Journal: Antimicrobial agents and chemotherapy

Published: December 26, 2014

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

Journal: Nature communications

Published: September 15, 2014

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

Journal: Journal of medicinal chemistry

Published: July 10, 2014

1,4-azaindole, a potential drug candidate for treatment of tuberculosis.

1,4-azaindole, a potential drug candidate for treatment of tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: June 25, 2014

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

Journal: Journal of medicinal chemistry

Published: June 11, 2014

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Journal: Journal of medicinal chemistry

Published: May 31, 2014

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

Journal: Journal of medicinal chemistry

Published: May 30, 2014

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.

Journal: Journal of medicinal chemistry

Published: May 09, 2014

Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

Journal: ACS medicinal chemistry letters

Published: April 29, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026